Understanding the deeper complexities of the immune system is critical to providing insights into immune based therapeutic candidates and their functioning.The IntelliCyt® iQue Screener PLUS platform is a high throughput suspension cell screening platform that facilitates simultaneous assessment of multiple parameters such as cell health and function from multiple cell types in a single well, while using minimal sample volumes.
Visit us at Booth #302 at Antibody Engineering & Therapeutics in San Diego, CA.
Visit us at Booth #2700 at the ASH Annual Meeting in Atlanta, GA.
Visit us at Booth #45 at PEGS Europe in Lisbon, Portugal.
Visit us at the Joint Annual Meeting of the French Society for Immunology & French Cytometry Association in Reims, France.
Visit us at the European Antibody Congress in Basel, Switzerland.
Detailed antibody characterization is a critical component of the discovery process for therapeutic monoclonal antibodies (MAbs).
Learn how the iQue® Screener PLUS platform and the IncuCyte® live-cell analysis platform can accelerate discovery and development of new therapies and provide new insights into the mechanisms of disease at the speed, depth and scale unachievable with conventional cell analysis techniques.
Visit us at the World Vaccine Congress Europe in Barcelona, Spain.
Visit us at the LakePharma Protein Engineering Symposium in So. San Francisco, CA.
Visit us at ELRIG Drug Discovery 2017 in Liverpool, UK.
Visit us at the GLIIFCA 2017 Conference in Middleton, Wisconsin.
Visit us at the CAR-TCR Summit in Boston, MA.
Visit us at Booth #26 at the Immuno Oncology Summit in Boston, MA.
Visit us at the American Society for Virology Annual Meeting in Madison, WI.
Visit us at Booth #205 at the 16th Annual World Preclinical Congress in Boston, MA.
Visit us at booth #1107 at CYTO 2017 in Boston, MA.
In cell line development, the identification and selection of optimal clones that secrete high levels of antibody into the culture supernatant is imperative.
Visit us at the 2nd Annual Advances in Immuno-Oncology Congress in London, UK.
Visit us at booth #908 at AAI 2017 in Washington, DC.
Visit us at the ELRIG Advances in Cell Based Screening conference in Gottinburg, Sweden.
Visit us at booth #103 at the American Society of Gene and Cell Therapy annual meeting in Washington, DC.
Visit us at Biomedical Research Equipment and Supplies in Fort Detrick, MD.
Visit us at Booth #416 at PEGS Boston.
Visit us at Booth #22 at the Protein and Antibodies Congress in London, UK.
Visit us at the sixth annual Southern California Flow Cytometry Association Summit 2017 in San Diego.
Visit us at Sartorius Booth #58 at the World Vacccine Congress in Washington, DC.
Visit us at the AACR Annual Meeting in Washington, DC.
Visit us at the 9th Annual International Congress of Antibody in Beijing, China.
Visit us at booth #T2 at PEGS China in Shanghai, China.
Visit us at Booth #2 at the Immuno-Oncology Summit Europe in London, UK.
Visit us at Booth #1721 at ToxExpo in Baltimore, Maryland.
Visit us at the Sartorius Research Xchange Forum in Goettingen, Germany.
Visit us at Booth #1037 at SLAS 2017 in Washington, DC.
In this webinar hosted by GEN, you will learn how the Finnish Institute of Molecular Medicine (FIMM) and AstraZeneca leveraged the unique capabilities of IntelliCyt’s iQue Screener platform to generate high-content data at high-speeds on heterogeneous cell populations.
Visit us at the Antibody Engineering & Therapeutics conference in San Diego, CA.
Visit us at the BSI Congress in Liverpool, UK.
Visit us at the ASH Annual Meeting in San Diego, CA.
Visit us at bioProcessUK in Newcastle upon Tyne, UK.
Visit us at ELRIG Pharmaceutical Flow Cytometry & Imaging in Stevenage, UK.
Visit us and Bucher Biotec at the European Antibody Congress in Basel, Switzerland.
Visit us at Cytométrie 2016 in Montpellier, France.
This webinar will be hosted by Drug Discovery World and presented by Mei Ding, Ph.D., Associate Principal Scientist from AstraZeneca and Tamara Laskowski, Ph.D., Post Doctoral Fellow from MD Anderson Cancer Center.
This webinar will be hosted by Xtalks and presented by Andrea Gorlani, Ph.D., Scientist from ModiQuest Research and Thomas Duensing, Ph.D., Chief Technology Officer from IntelliCyt Corporation
Visit us at PEGS Europe in Lisbon, Portugal.
Learn how our users are leveraging IntelliCyt products to unravel complex biology.
Visit us at the European Society of Gene and Cell Therapy in Florence, Italy.
Visit us at MetroFlow in Union, NJ.
Visit us at ELRIG Drug Discovery in Liverpool, UK.
Visit us at the New England Cytometry Fall Meeting in Cambridge, MA.
Visit us at the Northeast Regional Life Sciences Core Directors Meeting in Boston, MA.
Visit us at the Protein Engineering Symposium in South San Francisco, CA.
Visit us at the DGFZ Annual Meeting in Berlin, Germany.
The webinar will be hosted by Drug Target Review and will be presented by David Sykes, M.D., Ph.D., Researcher from Massachusetts General Hospital and Thibault Jonckheere, CEO and Séverine Giltaire, Senior Scientist from ImmunXperts.
Visit us at the American Society for Histocompatibility and Immunogenetics Annual Meeting in St. Louis, MO.
Visit us and Bucher Biotec at MipTec in Basel, Switzerland.
Visit us at ILMAC in Basel, Switzerland.
Visit us at GLIIFCA in Troy, MI.
Visit us at the CAR-TCR Summit in Boston, MA.
The use of re-directed T-cells to target and eliminate tumor cells has gained significant momentum over the recent years. Assessing each modified T-cell population for critical processes such as activation, tumor specific cytotoxicity, and persistence is essential to understanding the effect of these potential therapies.
Visit us at Booth #14 at the Immuno Oncology Summit in Boston, MA.
Visit us at the International Congress of Immunology in Melbourne, Australia.
Visit us at Table A at the 39th Annual Course in Cytometry Methods and Applications at Bowdoin College in Brunswick, Maine.
Visit us at Booth #604 at the World Preclinical Congress in Boston, MA.
Visit us at Booth #132 at CYTO 2016 in Seattle, WA.
Visit us at LRIG Mölndal, Sweden.
Visit us at Booth #20155 at the ASCO Annual Meeting in Chicago, IL.
Visit us at AH Diagnostics’ Seminar Day in Copenhagen, Denmark.
Visit us at Booth #2202 at AAI Immunology 2016 in Seattle, WA.
Visit us at LRIG Mid-Atlantic in Somerset, NJ.
Visit us at Booth# 319 at the American Society of Gene and Cell Therapy Annual Meeting in Washington, DC.
Register for this webinar to learn more about new tools that can advance the discovery of immunotherapeutics.
Visit us at LRIG Philadelphia in King of Prussia, PA.
Visit us at the SoCal Flow Summit at the Beckman Center, UC Irvine, California.
Visit us at Booth# 224 at PEGS Boston at the Seaport World Trade Center in Boston, MA.
Visit us at the Proteins & Antibodies Congress in London, UK.
Visit us at Booth# 2424 at the AACR Annual Meeting in New Orleans, LA.
Visit us at LRIG DC Metro in Potomac, MD.
Visit us at the Southeast Flow Cytometry Interest Group in Birmingham, AL.
Visit us at the European Laboratory Research & Innovation Group (ELRIG) Research and Innovation conference in Trent Vineyard, Nottingham, UK.
Visit us at Booth# 1436 at ToxExpo in New Orleans, LA.
Visit us at the Biotherapeutics Analytical Summit in Bethesda, MD.
Visit us at Booth# 106 at the Predictive Preclinical Models in Oncology conference in San Francisco, CA.
Visit us at the ADOPT Summit March 2-3, 2016 at the Kensington Close Hotel in London, UK.
Visit us at Booth# 216 at the ABRF Annual Meeting in Ft. Lauderdale, FL.
Visit us at the Translational Research Cancer Centers Consortium (TRCCC) Annual Meeting in Seven Springs, PA.
Visit us at Booth# 11 at the Antibodies in Drug Discovery Exhibition in Cambridge, UK.
Visit us at the FlowTex 9th Annual Cytometry Conference in the Onstead Auditorium at the Texas Medical Center in Houston, TX.
Visit us at Booth# 15 at the Immuno-Oncology 360° Conference at The New York Academy of Medicine in New York, NY.
Visit IntelliCyt at SLAS2016, the leading annual screening and automation meeting, in San Diego, CA. We will be at Booth #941.
This webinar will review how researchers at SpectraGenetics were able to run a new family of cell based assays to detect and quantify GPCR trafficking events using the iQue Screener platform.
Visit us at Booth# 306 at the Antibody Engineering and Therapeutics Conference